Caveolin: A key target for modulating nitric oxide availability in health and disease

Molecular and Cellular Biochemistry

Volumn 247, Issue 1-2, 2003, Pages 101-109

  Dhillon, Bikramjit ^a   Badiwala, Mitesh V ^a   Li, Shu Hong ^a   Li, Ren Ke ^a   Weisel, Richard D ^a   Mickle, Donald A G ^a   Fedak, Paul W M ^a   Rao, Vivek ^a   Verma, Subodh ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Caveolin; Endothelial nitric oxide synthase; Nitric oxide

Indexed keywords

CAVEOLIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CELL COMMUNICATION; CELL MEMBRANE; DRUG TARGETING; ENDOTHELIUM; ENZYME REGULATION; HUMAN; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW;

ANIMALS; BIOLOGICAL AVAILABILITY; CALCIUM; CAVEOLAE; CAVEOLIN 1; CAVEOLINS; HEALTH; HUMANS; MOLECULAR CHAPERONES; NITRIC OXIDE; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0038757638     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024198518582     Document Type: Review

References (69)

1. Smart EJ, Graf GA, McNiven MA, Sessa WA, Engelman JA, Scherer PE, Okamoto T, Lisanti MP: Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 19: 7289-7304, 1999
2. Predescu D, Predescu S, McQuistan T, Palade GE: Transcytosis of α1-acidic glycoprotein in the continuous microvascular endothelial. Proc Natl Acad Sci USA 95: 6175-6180, 1998
3. Glenny JR Jr: The sequence of human caveolin reveals identity with VIP21, a component of transport vesicles. FEBS Lett 314: 45-48, 1992
4. Shaul PW, Anderson RG: Role of plasmalemmal caveolae in signal transduction. Am J Pysiol 275: L843-L851, 1998
5. Fielding PE, Fielding CJ: Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry 34: 14288-14292, 1995
6. Palade GE: Fine structure of blood capillaries. J Appl Physiol 24: 1424-1436, 1953
7. Yamada E: The fine structure of the gall bladder of the mouse. J Biophys Biochem Cytol 1: 445-458, 1955
8. Smart EJ, Ying Y, Donzell WC, Anderson RG: A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J Biol Chem 271: 29427-29435, 1996
9. Fra AM, Williamson E, Simons K, Parton RG: De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci USA 92: 8655-8659, 1995
10. Li S, Song KS, Koh SS, Kikuchi A, Lisanti MP: Baculovirus-based expression of mammalian caveolin in Sf21 insect cells. A model system for the biochemical and morphological study of caveolae biogenesis. J Biol Chem 271: 28647-28654, 1996
11. Glenney JR Jr, Soppet D: Sequence and expression of caveolin a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci USA 89: 10517-10521, 1992
12. Dietzen DJ, Hastings WR, Lublin DM: Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae. J Biol Chem 270: 6838-6842, 1995
13. Garcia-Cardena G, Oh P, Liu J, Schnitzer JE, Sessa WC: Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide signaling. Proc Natl Acad Sci USA 93: 6448-6453, 1996
14. Sargiacomo M, Scherer PE, Tang Z, Kubler E, Song KS, Sanders MC, Lisanti MP: Oligomeric structure of caveolin: Implications for caveolae membrane organization. Proc Natl Acad Sci USA 92: 9407-9411, 1995
15. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP: Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 272: 6525-6533, 1997
16. Couet J, Li S, Okamoto T, Scherer PE, Lisanti MP: Molecular and cellular biology of caveolae. Paradoxes and plasticities. Trends Cardiovasc Med 7: 103-110, 1997
17. Das K, Lewis RY, Scherer PE, Lisanti MP: The membrane-spanning domains of caveolins-1 and -2 mediate the formation of caveolin heterooligomers. Implications for the assembly of caveolae membranes in vivo. J Biol Chem 274: 18721-18728, 1999
18. Schlegel A, Schwab RB, Scherer PE, Lisanti MP: A role for the caveolin scaffolding domain in mediating the membrane binding in vitro. J Biol Chem 274: 22660-22667, 1999
19. Schlegel A, Lisanti MP: A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo. J Biol Chem 275: 21605-21617, 2000
20. Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 271: 2255-2261, 1996
21. Garcia-Cardena G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP, Sessa WC. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem 272: 25437-25440, 1997
22. Venema VJ, Ju H, Zou R, Venema RC. Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J Biol Chem 272: 28187-28190, 1997
23. Brown D, Rose JK: Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68: 533-544, 1992
24. Schnitzer J, McIntosh D, Dvorak AM, Liu J, Oh P: Separation of caveolae from associated mircodomains of GPI-anchored proteins. Science 269: 1435-1439, 1995
25. Garcia-Cardena G, Martasek P, Siler-Masters BS, Skidd PM, Couet JC, Li S, Lisanti MP, Sessa WC: Dissecting the interaction between nitric oxide synthase (NOS) and caveolin: Functional significance of the NOS caveolin binding domain in vivo. J Biol Chem 272: 25437-25440, 1998
26. Gosh S, Gachhui R, Crooks C, Wu C, Lisanti MP, Stuehr DJ: Interactions between caveolin-1 and the reductase domain of endothelial nitric oxide synthase. Consequences for catalysis. J Biol Chem 273: 22267-22271, 1998
27. Ju H, Zou R, Venema VJ, Venema RC: Direct interaction of endothelial nitric oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem 272: 18522-18525, 1997
28. Crane BR, Arvai AS, Ghosh DK, Wu C, Getzoff ED, Stuehr DJ, Tainer JA: Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 279: 2121-2126, 1998
29. Michel T, Li GK, Busconi L: Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci 90: 6252-6256, 1993
30. Fleming I, Bauersachs J, Fisslthaler B, Busse R: Ca2+-independent activation of the endothelial nitric oxide syntase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circ Res 82: 686-695, 1998
31. Corson MA, James NL, Latta SE, Nerem RM, Berk BC, Harrison DG: Phosphorylation of endothelial nitric oxide synathase in response to fluid shear stress. Circ Res 79: 984-991, 1996
32. Garcia-Cardena F, Fan R, Stern DF, Liu J, Sessa WC: Endothelial nitric oxide synathase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem 271: 27237-27240, 1996
33. Nathan C, Xie QW: Regulation of biosynthesis of nitric oxide. J Biol Chem 269: 13725-13728, 1994
34. Venema RC, Sayegh HS, Arnal J-F, Harrison DG: Identification, characterization, and comparison of the calmodulin-binding domains of the endothelial and inducible nitric oxide synthase. J Biol Chem 270: 14705-14711, 1995
35. Fleming I, Busse R: Signal transduction of eNOS activation. Cardiovascular Res 43: 532-541, 1999
36. Gachhui R, Abu-Soud HM, Ghosha DK, Presta A, Blazing MA, Mayer B, George SE, Stuehr DJ: Neuronal nitric oxide synthase interaction with calmodulin-troponin C chimeras. J Biol Chem 273: 22267-22271, 1998
37. Salerno JC, Harris DE, Irizarry K, Patel B, Morales AJ, Smith SM, Martasek P, Roman LJ, Masters BS, Jones CL, Weissman BA, Lane P, Liu Q, Gross SS: An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase. J Biol Chem 272: 29769-29777, 1997
38. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RG, Michel T: Acylation targets endothelial nitric oxide synthase to plasmalemmal caveolae. J Biol Chem 271: 6518-6522, 1996
39. Shaul PW, Anderson RG: Role of plasmalemmal caveolae in signal transduction. Am J Physiol 275: L843-L851, 1998
40. Okamoto T, Schlegel A, Scherer PE, Lisanti MP: Caveolins, a family of scaffolding proteins for organizing 'preassembled signal complexes' at the plasma membrane. J Biol Chem 273: 5419-5422, 1998
41. Fleming I, Busse R: Signal transduction of eNOS activation. Cardiovascular Res 43: 532-541, 1999
42. 2+-calmodulin and caveolin. J Biol Chem 272: 15583-15586, 1997
43. Feron O, Saldana F, Michel JB, Michel T: The endothelial nitric-oxide synthase-caveolin regulatory cycle. J Biol Chem 273: 3125-3128, 1998
44. Michel T, Li GK, Busconi L: Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad USA 90: 6252-6256, 1993
45. Ayajiki K, Kindermann M, Hecker M, Fleming I, Busse R: Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells: Circ Res 78: 750-758, 1996
46. Ju H, Venema VJ, Marrero MB, Venema RC: Inhibitory interactions of the bradykinin B2 receptor with endothelial nitric oxide synthase. J Biol Chem 273: 24025-24029, 1998
47. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, Sessa WC: Dynamic activation of endothelial nitric oxide synthase by Hsp 90. Nature 392: 821-824, 1998
48. Vane JR, Anggard EE, Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 323: 27-36, 1990
49. Feron O, Dessy C, Moniotte S, Desager JP, Balligand JL: Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 103: 897-905, 1999
50. Blair A, Shaul PW, Yuhanna IS, Conrad PA, Smart E J: Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J Biol Chem 274: 32512-32519, 1999
51. Uittenbogaard A, Shaul PW, Yuhanna IS, Blair A, Smart EJ: High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide syntase localization and activation in caveolae. J Biol Chem 275: 11278-11283, 2000
52. Maron DJ, Fazio S, Linton MF: Current perspectives on statins. Circulation 101: 207-213, 2000
53. Takemoto M, Liao JK: Pleiotropic effects of 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol 11: 1712-9, 2001
54. Dumont AS, Hyndman ME, Dumont RJ, Fedak PM, Kassell NF, Sutherland GR, Verma S: Improvement of endothelial function in insulin-resistant carotid arteries treated with pravastatin. J Neurosurg 95: 466-71, 2001
55. Feron O, Dessy C, Desager JP, Balligand JL: Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 103: 113-118, 2001
56. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP: Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 271: 15160-15165, 1996
57. Campbell L, Gumbleton M, Ritchie K: Caveolae and the caveolins in human disease. Adv Drug Del Rev 49: 325-335, 2001
58. Sotgia F, Lee JK, Das K, Bedford M, Petrucci TC, Macioce P, Sargiacomo M, Bricarelli FD, Minetti C, Sudol M, Lisanti MP: Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members. J Biol Chem 275: 38048-38058, 2000
59. Repetto S, Bado M, Broda P, Lucania G, Masetti E, Sotgia F, Carbone I, Pavan A, Bonilla E, Cordone G, Lisanti MP, Minetti C: Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. Biochem Biophys Res Commun 261: 547-550, 1999
60. Vaghy PL, Fang J, Wu W, Vaghy LP: Increased caveolin-3 levels in mdx mouse muscles. FEBS Lett 431: 125-127, 1998
61. Volonte D, Galbiati F, Lisanti MP: Visualization of caveolin-1, a caveolar marker protein, in living cells using green fluorescent protein (GFP) chimeras. The subcellular distribution of caveolin-1 is modulated by cell-cell contact. FEBS Lett 445: 431-439, 1999
62. Sager R, Sheng S, Anisowicz A, Sotiropoulou G, Zou Z, Stenman G, Swisshelm K, Chen Z, Hendrix MJ, Pemberton P et al.: RNA genetics of breast cancer: Maspin as paradigm. Cold Spring Harb Symp Quant Biol 59:537-546, 1994
63. Koleske AJ, Baltimore D, Lisanti MP: Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 92: 1381-1385, 1995
64. Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG, Lisanti MP: Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 17: 6633-6648, 1998
65. Piech A, Massart PE, Dessy C, Feron O, Havaux X, Morel N, Vanoverschelde JL, Donckier J, Balligand JL: Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 282: H219-H231, 2002
66. Gyurko R, Kuhlencordt P, Fishman MC, Huang PL: Modulation of mouse cardiac function in vivo by eNOS and ANR Am J Physiol Heart Circ Physiol 278: H971-H981, 2000
67. Grocott-Mason R, Anning P, Evans H, Lewis MJ, Shah AM: Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol 267: H1804-H1813, 1994
68. Keaney JF Jr, Hare JM, Balligand JL, Loscalzo J, Smith TW, Colucci WS: Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation. Am J Physiol 271: H2646-H2652, 1996
69. Shen W, Xu X, Ochoa M, Zhao G, Wolin MS, Hintze TH: Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res 75: 1086-1095, 1994